BFA
ABBV icon

BMS Financial Advisors’s AbbVie ABBV Stock Holding History

BMS Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$642K Sell
4,768
-1,883
-28% -$276K 0.42% 38
2023
Q1 		$1.06M Sell
6,651
-139
-2% -$21.3K 0.73% 22
2022
Q4 		$1.1M Sell
6,790
-119
-2% -$18.2K 0.73% 20
2022
Q3 		$927K Sell
6,909
-237
-3% -$34K 0.65% 23
2022
Q2 		$1.09M Sell
7,146
-281
-4% -$42.9K 0.72% 21
2022
Q1 		$1.2M Buy
7,427
+73
+1% +$10.6K 0.77% 24
2021
Q4 		$996K Buy
+7,354
New +$869K 0.63% 25

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BMS Financial Advisors's ABBV Position: Q2 2023 in Review

BMS Financial Advisors reduced its AbbVie (ABBV) stake by 28% in Q2 2023, selling an estimated $276K and leaving 4,768 shares worth $642K. The position accounts for 0.42% of the portfolio, ranked #38.

BMS Financial Advisors first reported a position in ABBV in Q4 2021 and has held it in 7 quarters since. The position peaked at $1.2M in Q1 2022. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

  • BMS Financial Advisors held 4,768 shares of AbbVie worth $642K as of Q2 2023.
  • BMS Financial Advisors sold 1,883 AbbVie shares in Q2 2023, an estimated $276K.
  • AbbVie made up 0.42% of BMS Financial Advisors's portfolio in Q2 2023, its #38 holding.
  • BMS Financial Advisors first reported a position in AbbVie in Q4 2021 and has held it in 7 quarters since.
  • BMS Financial Advisors's AbbVie position peaked at $1.2M in Q1 2022.
  • 3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on BMS Financial Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.